BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23532107)

  • 21. Fundic gland differentiation of oncocytic/pancreatobiliary subtypes of pancreatic intraductal papillary mucinous neoplasm.
    Mamat O; Fukumura Y; Saito T; Takahashi M; Mitomi H; Sai JK; Kawasaki S; Yao T
    Histopathology; 2016 Oct; 69(4):570-81. PubMed ID: 26990132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
    Sanada Y; Kunita S; Yoshida K
    Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
    Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
    Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas may have 2 subtypes with distinct clinicopathologic and genetic features.
    Shimizu T; Akita M; Sofue K; Toyama H; Itoh T; Fukumoto T; Zen Y
    Hum Pathol; 2019 Sep; 91():26-35. PubMed ID: 31175918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
    Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
    Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraductal Papillary Mucinous Neoplasms Often Contain Epithelium From Multiple Subtypes and/or Are Unclassifiable.
    Schaberg KB; DiMaio MA; Longacre TA
    Am J Surg Pathol; 2016 Jan; 40(1):44-50. PubMed ID: 26469398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.
    Sadakari Y; Ohuchida K; Nakata K; Ohtsuka T; Aishima S; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Surgery; 2010 Jun; 147(6):812-7. PubMed ID: 20060146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant transformation and overall survival of morphological subtypes of intraductal papillary mucinous neoplasms of the pancreas: A network meta-analysis.
    Qi X; Zhao X; Su J; Xu M; Zhang W; Sheng H; Li Z; Wang J
    Eur J Intern Med; 2015 Oct; 26(8):652-7. PubMed ID: 26275457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular profile of apomucin and p53 protein as predictors of malignancy in intraductal papillary mucinous neoplasms of the pancreas.
    Mizumoto M; Honjo G; Kobashi Y; Awane M; Matsusue S
    Hepatogastroenterology; 2011; 58(110-111):1791-5. PubMed ID: 22086702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
    Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
    Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of epithelial subtypes of intraductal papillary mucinous neoplasm of the pancreas with endoscopic ultrasound and cyst fluid analysis.
    Yoon WJ; Daglilar ES; Mino-Kenudson M; Morales-Oyarvide V; Pitman MB; Brugge WR
    Endoscopy; 2014 Dec; 46(12):1071-7. PubMed ID: 25208034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
    Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
    Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.
    Castellano-Megías VM; Andrés CI; López-Alonso G; Colina-Ruizdelgado F
    World J Gastrointest Oncol; 2014 Sep; 6(9):311-24. PubMed ID: 25232456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
    Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS
    Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
    Takahashi H; Nakamori S; Nakahira S; Tsujie M; Takahshi Y; Marubashi S; Miyamoto A; Takeda Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Ann Surg Oncol; 2006 Jul; 13(7):955-60. PubMed ID: 16788757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
    J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas.
    Ohtsuka T; Kono H; Tanabe R; Nagayoshi Y; Mori Y; Sadakari Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
    Am J Surg; 2012 Jul; 204(1):44-8. PubMed ID: 21996346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis.
    Tamura K; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Ideno N; Aso T; Miyazaki T; Ohuchida K; Takahata S; Ito T; Ushijima Y; Oda Y; Mizumoto K; Tanaka M
    Surgery; 2015 Feb; 157(2):277-84. PubMed ID: 25530484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal papillary mucinous neoplasms of the pancreas.
    Gourgiotis S; Ridolfini MP; Germanos S
    Eur J Surg Oncol; 2007 Aug; 33(6):678-84. PubMed ID: 17207960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.